News
BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...
The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.
Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...
8d
Pharmaceutical Technology on MSNBiohaven secures $600m financing as it awaits FDA prodrug decisionBiotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...
Currently under review in the U.S. for a rare genetic disorder, the drug is seen by some investors as critical to Biohaven’s ...
Biohaven, after setbacks, sees shares jump with Oberland Capital funding agreement worth up to $600M
Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 ...
Eric Dane revealed he's been diagnosed with amyotrophic lateral sclerosis, also known as ALS. Here's what to know about the rare disease.
The drug riluzole, marketed under the brand name Rilutek, was the first treatment approved by the Food and Drug Administration. The drug was approved in 2017. A glutamatergic antagonist ...
Actor Eric Dane, 52, revealed this week that he has been diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. “I have been diagnosed with ALS. I am grateful ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Medicines like riluzole and edaravone can help extend life by a few months and slow down the damage to motor neurons. Physical therapy, speech therapy, and nutritional support are key parts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results